COVID-19 vaccine gave 100 per cent protection against severe/critical illness to study volunteers, research shows
Results from a COVID-19 vaccine trial – to which MFT consented the first global participant – are ‘extremely positive’.
Read moreResults from a COVID-19 vaccine trial – to which MFT consented the first global participant – are ‘extremely positive’.
Read moreThe country’s largest clinical study investigating the best gap between first and second COVID-19 vaccine doses for pregnant women has launched in Greater Manchester.
Read moreDr Stephanie Ling, Clinical Research Fellow at Manchester Royal Infirmary, discusses working with rheumatoid arthritis patients through research to improve biologic treatments.
Read moreTwo researchers from Manchester University NHS Foundation Trust (MFT) have been named as winners in the Royal College of Physicians (RCP) and National Institute for Health Research (NIHR) Clinical Res
Read moreA phase one trial of one of the world’s first multivariant COVID-19 Vaccine has been launched by US pharmaceutical company Gritstone, in collaboration with MFT.
Read moreA 70-year-old woman, forced to live with cough since her 40s, is ‘excited’ to be the first person in the world to receive a potential new cough treatment.
Read moreManchester University NHS Foundation Trust is opening themselves up to a three-month reflective assessment of their delivery of race equality in health research.
Read morePeople across Greater Manchester are being asked to play their part in helping vital research into new COVID-19 treatments.
Read more